If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 7 Jul: New Phase 1 trial launches to evaluate IAVI-developed HIV broadly neutralizing antibody
• 22 Jul: Phase 2b clinical trial of promising TB vaccine candidate MTBVAC has reached full enrollment
• 14 Jul: TB Alliance case study on expanding access to lifesaving tuberculosis treatments published by INSEAD
• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns
• 27 Jul: Thai FDA approves NUZOLVENCE® (zoliflodacin) just six months after US authorization
• 2 Jul: From innovation to access: ensuring lifesaving solutions reach those who need them
• 27 Jul: The diagnostics deficit: Funding, access, and preparedness gaps in African health systems
• 9 Jul: MMV and deepmirror continue partnership to advance AI tool for global health drug discovery
• 15 Jul: New malaria drug candidate shows early promise in human study
• 21 Jul: Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools
• 8 Jul: Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India
• 13 Jul: DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
• 13 Jul: DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
• 27 Jul: DNDi leadership to change in 2027
• 10 Jul: FIND Board Announces Board Chair Transition
• 8 Jun: IVI partners in ACT-CHIK consortium to advance chikungunya vaccine development and manufacturing in Africa
• 26 Jun: IVI, KDCA, and RIGHT Foundation host 2026 Global Vaccine Forum on advancing equitable access to next-generation vaccines
MDGH
• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction
PDP Funder News/Announcements
• 11 Aug: The evidence behind medicines made in Africa. Unitaid
• 11 Aug: Tackling schistosomiasis in Tanzania's young children. Wellcome
• 14 Jul: PATH and Unitaid partner with GiveWell to strengthen integrated HIV and syphilis testing for mothers, newborns, and their families. Unitaid
• 17 Jul: Unitaid and CHAI cut cost of AI screening software, unlocking affordable TB detection in communities without radiologists. Unitaid
• 22 Jul: CAPTURE-1 study advances development of a novel single-dose malaria treatment. EDCTP
• 22 Jul: Oil price shocks could raise the cost of HIV medicines by up to 44%, Unitaid analysis finds. Unitaid
• 23 Jul: Increasing Our 2026 Allocation to GiveWell’s Recommendations to $1 Billion. Coefficient Giving
• 23 Jul: Unitaid invests an additional US$15 million to accelerate introduction, adoption and uptake of breakthrough HIV prevention products in diverse regions. Unitaid
• 23 Jul: Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools. GHIT
• 24 Jul: Unitaid strengthens African manufacturing capacity for next-generation HIV prevention medicines. Unitaid
• 27 Jul: Unitaid Board appoints Dr. Luis Pizarro as Unitaid’s next Executive Director. Unitaid
• 31 Jul: EDCTP2 demonstrates impact on health, policy and research capacity. EDCTP2
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 29 Jun: Advancing global health innovation through Europe-Africa collaboration. Numerous PDPs
Other Reports/ Publications
• Jun: From innovation to impact: Building on 20 years of progress. Unitaid
• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies
Related Press Releases/ Announcements/Articles
• 1 Jul: Study reveals path for universal vaccine against malaria. OHSU
• 1 Jul: Gavi launches new supply chain strategy to boost vaccine availability and reach remote communities. Gavi
• 2 Jul: Ebola Antiviral Trial Begins at Secret Facility Amid Attacks on Treatment Centres. Health Policy Watch
• 2 Aug: With a Series of Big Donations, State Department Restores Some Global Health Aid. The New York Times
• 3 Aug: Scientists Warn Drug-Resistant Malaria Mutation Is Spreading Across Lake Victoria Basin. Health Policy Watch
• 3 Aug: The Accra Reset: Reimagining Global Health Governance in an Era of Fragmentation. Global Policy
• 3 Aug: Inside the trial for a vaccine to end malaria. The Telegraph
• 3 Aug: A new chapter for African medical innovation. Nature
• 3 Aug: Moderna’s Bundibugyo ebolavirus vaccine candidate enters first human trial, backed by CEPI. CEPI
• 4 Aug: Reforming global health for an age of mistrust, fragmentation and overlapping crises. Nature
• 4 Aug: Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says. Reuters
• 4 Aug: Moderna begins first human trial of Bundibugyo Ebola vaccine. Reuters
• 4 Aug: Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study. The Lancet
• 4 Aug: Scientists Warn Drug-Resistant Malaria Mutation Is Spreading Across Lake Victoria Basin. Health Policy Watch
• 4 Aug: Climate change is shifting malaria activity in Africa. CIDRAP
• 4 Aug: Revvity reveals plans to expand latent tuberculosis testing business at ADLM. 360Dx
• 4 Aug: As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles. Science
• 4 Aug: Antimalaria pesticide may have backfired, helping mosquitoes find love. Science
• 4 Aug: An Invasive Mosquito Is Spreading With Alarming Speed, Threatening Africa’s Cities. The New York Times
• 5 Aug: Accelerating policy approval and uptake of the dual prevention pill in Zambia through early stakeholder engagement. AIDS Care
• 6 Aug: The Machine in Geneva’s Basement. Health Policy Watch
• 6 Aug: To stop Ebola, treat malaria. Devex
• 6 Aug: Ebola virus behind massive outbreak in DRC could be mutating, officials say. The Guardian
• 6 Aug: EXCLUSIVE: Here is the ‘Final Text’ of UN Political Declaration on Pandemics – Although its Adoption is Far From Guaranteed. Health Policy Watch
• 7 Aug: Alarming Ebola Spread Raises Question of Viral Mutation. Health Policy Watch
• 7 Aug: Gavi welcomes recommendation to include existing Ebola vaccine Ervebo in clinical trials for Bundibugyo virus disease. Gavi
• 7 Aug: Lawmakers seek to boost new antibiotic development. CIDRAP
• 7 Aug: Third meeting of the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease outbreak response: meeting report, 31 July 2026. WHO
• 7 Aug: Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial. Al Jazeera
• 7 Aug: Nanophotonics offers new hope for early malaria diagnosis. Nature
• 10 Aug: Fridge-free vaccine passes first human trial, raising hopes for the hardest-to-reach. Gavi
• 10 Aug: How climate change is reshaping Africa's malaria risk. DW
• 10 Aug: Beyond restoration: Tipping points, leverage points and the reimagination of global health architecture. Global Public Health
• 10 Aug: White House Attempt to Control Science Grants is Blocked – For Now. Health Policy Watch
• 10 Aug: We prepared for Ebola — but not this Ebola. STAT
• 10 Aug: AI Philanthropy Should Buy the Breakthroughs Markets Won’t. CGD
• 11 Aug: India’s homegrown malaria vaccine still a couple of years away from potential rollout, says ICMR chief. The Print
• 11 Aug: Ebola deaths top 2,000 as scientists race to develop vaccine. UN News
• 11 Aug: Phase 3 trial of Ebola vaccine to begin within weeks in Congo. Healio
• 11 Aug: Why bioequivalence is central to Africa’s manufacturing future. USP
• 11 Aug: The race to develop a vaccine for world’s fastest spreading Ebola. Geneva Solutions
• 12 Aug: Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says. STAT
• 12 Aug: At the heart of accelerating chikungunya vaccine development for Africa. CEPI
• 13 Aug: A boost for chemical vaccination against malaria. Science
• 13 Aug: Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria. Science
• 13 Aug: New vaccination approach turns mosquito bites into immunity boosters. News Medical
• 13 Aug: Leading Malaria Scientist Warns Tools Alone Will Not End the Disease. Health Policy Watch
• 14 Aug: AI-created bacteriophage overcame resistant bacterial strains, but experts emphasize need for safeguards. CIDRAP
• 14 Aug: Scaling up malaria vaccines in Africa. BMJ
• 14 Aug: CEPI Board appoints Ibrahim Abubakar as new Chief Executive Officer. CEPI
• 14 Aug: Guiding principles for pragmatic randomised trials of tuberculosis treatments. The Lancet
• 15 Aug: The next global health architecture cannot exclude women. The Lancet
• 15 Jul: Tuberculosis testing gets a massive boost. Nature
• 16 Jul: India's Serum Institute partners with Gates MRI to make experimental TB vaccine. Reuters
• 16 Jul: The Bundibugyo wake-up call: why the UK cannot afford to ignore the latest Ebola outbreak. Bond
• 16 Jul: GSK-developed TB vaccine candidate progresses toward global access with new manufacturing agreement. GSK
• 17 Aug: New malaria compound could simplify treatment with single dose. Health Tech World
• 17 Aug: We cannot afford to lose the fight against drug-resistant malaria. GHTC
• 17 Aug: New genetic mutations linked to malaria drug resistance discovered. News Medical
• 17 Aug: Why Unitaid’s incoming chief says global health must keep innovating. Devex
• 17 Jul: PABS deferred: the rise of bilateralism and future of pandemic governance. The Lancet
• 18 Aug: High-Profile Departures Shake Up WHO Leadership, Tedros ‘Confidant’ Returns. Health Policy Watch
• 18 Aug: The Ebola situation is grave; we must use every tool we have to save lives. Gavi
• 18 Aug: Priorities for an African research agenda on climate, environment and maternal, newborn and child health. Frontiers
• 20 Jul: India approves first dengue vaccine as cases surge in South Asia. The Telegraph
• 20 Jul: Japanese drugmaker Takeda's QDENGA becomes first dengue vaccine approved in India. Reuters
• 20 Jul: Bill Gates on Africa’s Next Growth Story: Health, AI and Homegrown Innovation. CNBC Africa
• 21 Jul: Rapid spread of Ebola spurs ‘remarkably’ quick drug and vaccine trials. Science
• 21 Jul: How Scientists Can Revive Global Health Drug Development. Think Global Health
• 21 Jul: In ongoing trials, twice-yearly HIV prevention drug saw just one case. Devex
• 21 Jul: Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation. PLOS Med
• 21 Jul: Ebola Update: More than 2,000 cases, with 80% of new cases detected outside of contact lists. Geneva Health Files
• 22 Jul: Global impact and cost-effectiveness of tuberculosis interventions. Nature
• 22 Jul: An HIV vaccine is within reach. Vox
• 22 Jul: Smaller COVID-19 vaccine booster doses match full-dose protection for up to two years. CEPI
• 22 Jul: New study supports testing of Merck’s Ebola vaccine in DRC outbreak. STAT
• 22 Jul: Africa’s vaccine ambitions must move beyond fill-and-finish. Nature Africa
• 22 Jul: Climate change is driving dengue spread in low- and middle-income countries. CIDRAP
• 22 Jul: New study supports testing of Merck’s Ebola vaccine in DRC outbreak. STAT
• 22 Jul: African vaccine manufacturing is advancing, but the path to market has revealed challenges. CHAI
• 23 Jul: ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins. Fierce Biotech
• 23 Jul: Study finds malaria chemoprevention for school-aged children could deliver billions in health and economic benefits. MedicalXpress
• 23 Jul: Positive interim findings on new once-weekly HIV treatment pill. Spotlight
• 24 Jul: Reconceptualising Universal Health Coverage (UHC) for global distributive justice: The case of the Drugs for Neglected Diseases initiative. Global Public Health
• 24 Jul: With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access. The New York Times
• 24 Jul: A rocky rollout: A powerful new prevention drug could help end the HIV epidemic—but supply is falling far short. Science
• 24 Jul: South Africa: African Development Bank and Biovac sign $15 million agreement to advance Africa's first end-to-end cholera vaccine production. AFDB
• 25 Jul: Pregnancy as exclusion criterion in Ebola research: not again. The Lancet
• 25 Jul: Bundibugyo ebolavirus from the 2026 Ebola outbreak in Uganda and DR Congo: a new variant. The Lancet
• 27 Jul: WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs. WHO
• 27 Jul: High prices and funding cuts stall HIV prevention revolution. UN News
• 27 Jul: Four in five African patients miss accurate diagnoses at primary clinics: report. The East African
• 27 Jul: Africa’s New Medicines Regulator Wants to be More than Another Approval Channel. Health Policy Watch
• 27 Jul: Daily pill. Monthly pill. Six-monthly jab. Why choice matters. Bhekisisa
• 28 Jul: Towards a universal malaria vaccine. Nature
• 28 Jul: First volunteer gets Ebola vaccine — three months after the outbreak began. Nature
• 28 Jul: Reforming global health architecture requires confronting its political economy. BMJ
• 28 Jul: New Unitaid Head Gets High Marks – but Can He Save the Organization?. Health Policy Watch
• 28 Jul: Activists and leaders at global HIV meeting decry price of prevention drug. Science
• 28 Jul: In-home tongue swab testing for tuberculosis screening among household contacts in South Africa: a prospective cohort study. The Lancet
• 28 Jul: Innovation Without Access is Injustice: AIDS 2026 Opens in Rio. AVAC
• 28 Jul: Lenacapavir: A blueprint for innovation, regulation, and access. GHTC
• 28 Jul: First volunteer vaccinated in Ebola vaccine trial. CIDRAP
• 28 Jul: A not-for-profit medicine development model to address global health inequities. Dev Policy Blog
• 29 Jul: Brazil Pushes for Inclusion in Pharma Deals for Long-Acting HIV Prevention Drugs. Health Policy Watch
• 29 Jul: New HIV Frontier: The Fight to Access Long-Acting Prevention Drugs. Health Policy Watch
• 29 Jul: AIDS 2026: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in. Spotlight
• 29 Jul: #Aids2026: We analysed SA’s first LEN roll-out data. Here’s what we found. Bhekisisa
• 29 Jul: Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment. NEJM
• 29 Jul: How mosquitoes are conquering the world — in four charts. Nature
• 29 Jul: Breaking the taboo on including pregnant women in vaccine clinical trials. Gavi
• 29 Jul: WHO updates treatment guidelines on visceral and post-kala-azar dermal leishmaniasis. WHO
• 29 Jul: US finally moves to release $600 million to Gavi. Devex
• 30 Jul: CEPI-backed Bundibugyo ebolavirus vaccine doses for clinical trials. CEPI
• 30 Jul: Hilleman Laboratories to develop and produce CEPI-backed Bundibugyo ebolavirus vaccine doses for clinical trials. CEPI
• 30 Jul: World’s most mosquito-bitten district records sharp drop in hospitalisations since malaria jab. Gavi
• 30 Jul: Gavi Welcomes Restoration of US Funding – But No Clarity on How Agency will Phase out Thimerosal. Health Policy Watch
• 30 Jul: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP). Aidsmap
• 30 Jul: New drug for super-gonorrhoea points to better antibiotic development. The Telegraph
• 30 Jul: Africa Advances a New Model for Global Health Innovation. Africa CDC
• 30 Jul: Trump Pathogen Agreements and Global Equity Proposals. Public Citizen
• 30 Jul: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases. STAT
• 31 Jul: MedAccess’ $10m loan to help Biovac build end-to-end vaccine manufacturing facility in Cape Town. MedAccess
Upcoming Meetings/ Webinars
--------------------------